GlassScriptPhysician profile
Lloyd Chesney Dyas
NPI 1154313807
$3,192.32
in general payments reported to CMS, 2019-2025
16 companies · $747 in 2025
The $747 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,229 · 2020: $91.40 · 2021: $11.34 · 2022: $879 · 2023: $145 · 2024: $90.30 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655 · Travel and Lodging: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.63 |
| Travel and Lodging | $327.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,304.41 | 2022-2025 | Blueprint Patient Specific Instrumentation |
| Medacta USA, INC. | $1,164.14 | 2019 | |
| Smith+Nephew, INC. | $185.89 | 2022-2025 | Aetos Shoulder System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.13 | 2022-2024 | Relistor |
| Horizon Therapeutics Plc | $107.51 | 2020-2022 | |
| Kerecis Limited | $53.42 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Bioventus LLC | $52.00 | 2019 | |
| Depuy Synthes Sales INC. | $40.44 | 2022 | |
| Forte Bio-Pharma LLC | $30.73 | 2025 | Prolate, Tanlor, Nalocet |
| Radius Health, INC. | $26.23 | 2024 | Tymlos |
| Vertex Pharmaceuticals Incorporated | $23.02 | 2024 | |
| Integra Lifesciences Corporation | $22.16 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Solventum Corporation | $17.26 | 2025 | V.A.C. Veraflo, Prevena |
| Convatec INC. | $16.83 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $12.81 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $11.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lloyd Dyas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.